Aleva Neurotherapeutics SA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Aleva Neurotherapeutics SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6386
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aleva Neurotherapeutics SA (Aleva) is a medical device company that provides neuro-stimulation solutions. The company’s products include deep brain stimulation diagnostic systems and deep brain stimulation systems. Its deep brain stimulation systems provide directional stimulation for more precise area of the brain to be activated. Aleva’s deep brain stimulation diagnostic systems offer surgeries that first finds brain region using electrophysiological recordings. The company also provides micro system technologies that contain therapies that are optimized for effectiveness in each disease and individual patient and unique micro-fabricated devices enabling target specific stimulation. It offers its products across Switzerland. Aleva is headquartered in Lausanne, Switzerland.

Aleva Neurotherapeutics SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Aleva Neurotherapeutics SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Aleva Neurotherapeutics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Aleva Neurotherapeutics SA, Medical Equipment, Deal Details 10
Venture Financing 10
Aleva Neurotherapeutics Raises USD13 Million in Series D Financing 10
Aleva Neurotherapeutics Raises USD18 Million in Series C Financing Round 11
Aleva Neurotherapeutics to Raise Funds in Series C Financing 13
Aleva Neurotherapeutics Raises US$4.3 Million In Series B Financing 14
Partnerships 15
Aleva Neurotherapeutics Enters into Agreement with Greatbatch 15
Aleva Neurotherapeutics SA – Key Competitors 16
Aleva Neurotherapeutics SA – Key Employees 17
Aleva Neurotherapeutics SA – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Apr 24, 2018: Aleva Neurotherapeutics Strengthens Senior Management Team with Appointment of Two Industry Veterans 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Aleva Neurotherapeutics SA, Medical Equipment, Key Facts 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Aleva Neurotherapeutics SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Aleva Neurotherapeutics SA, Deals By Market, 2012 to YTD 2018 8
Aleva Neurotherapeutics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Aleva Neurotherapeutics Raises USD13 Million in Series D Financing 10
Aleva Neurotherapeutics Raises USD18 Million in Series C Financing Round 11
Aleva Neurotherapeutics to Raise Funds in Series C Financing 13
Aleva Neurotherapeutics Raises US$4.3 Million In Series B Financing 14
Aleva Neurotherapeutics Enters into Agreement with Greatbatch 15
Aleva Neurotherapeutics SA, Key Competitors 16
Aleva Neurotherapeutics SA, Key Employees 17

List of Figures
Aleva Neurotherapeutics SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Aleva Neurotherapeutics SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Aleva Neurotherapeutics SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Aleva Neurotherapeutics SA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aprecia Pharmaceuticals Company-製薬・医療分野:企業M&A・提携分析
    Summary Aprecia Pharmaceuticals Company (Aprecia) is a healthcare products provider that develops and markets various therapeutic products. The company's zipdos technology platform is used in the production of sponge-like wafer forms of existing medicines. It also offers 3D printing technology platf …
  • Bank of Tianjin Co Ltd:企業の戦略・SWOT・財務情報
    Bank of Tianjin Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of Tianjin Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析
    H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AmWINS Group Inc:企業のM&A・事業提携・投資動向
    AmWINS Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AmWINS Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Grupo Juste SAQF:製薬・医療:M&Aディール及び事業提携情報
    Summary Grupo Juste SAQF (Juste) is a developer and distributor of proprietary medicines and active pharmaceutical ingredients. The company offers oral and injectable radiological contrast media; diatrizoic acid, iothalamic acid, iohexol, iopamidol, iodixanol, MRI contrast agents, dihexazin, and oth …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Symbolic Displays, Inc.:企業の戦略・SWOT・財務情報
    Symbolic Displays, Inc. - Strategy, SWOT and Corporate Finance Report Summary Symbolic Displays, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Achaogen Inc (AKAO)-製薬・医療分野:企業M&A・提携分析
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company is developing plazomicin for the treatment of serious bacterial infections due to MDR E …
  • NetScout Systems, Inc. (NTCT):企業の財務・戦略的SWOT分析
    NetScout Systems, Inc. (NTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Oshkosh Corporation:企業の戦略・SWOT・財務情報
    Oshkosh Corporation - Strategy, SWOT and Corporate Finance Report Summary Oshkosh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Seoul City Gas Co Ltd (017390):企業の財務・戦略的SWOT分析
    Seoul City Gas Co Ltd (017390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • IntraPace Inc:医療機器:M&Aディール及び事業提携情報
    Summary IntraPace Inc (IntraPace) is a medical device company that develops novel implantable systems. The company offers abiliti systems that contain sensors intended to track consumption events and physical activity to direct when therapy is delivered and to monitor a patient's progress toward wei …
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Amedica Corp (AMDA):医療機器:M&Aディール及び事業提携情報
    Summary Amedica Corp (Amedica) is a biomaterial company that develops, produces and markets medical-grade silicon nitride ceramics for spinal implants and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems. It also offers non-silicon …
  • Sutro Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADC’s), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways. Its pipeline …
  • Rigel Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Spinal Elements Inc:医療機器:M&Aディール及び事業提携情報
    Summary Spinal Elements Inc (Spinal Elements), formerly Quantum Orthopedics Inc, a subsidiary of Spinal Elements, is a medical device manufacturing company that manufactures spinal implants and instruments. The company provides products such as cervical implant systems, anterior cervical plate syste …
  • NorthWestern Corporation:発電所・企業SWOT分析
    NorthWestern Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Sorrento Therapeutics, Inc.:企業のM&A・事業提携・投資動向
    Sorrento Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sorrento Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Toll Holdings Ltd:企業の戦略的SWOT分析
    Toll Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆